297 related articles for article (PubMed ID: 24593134)
1. Relationship between retinol-binding protein-4/adiponectin and leptin/adiponectin ratios with insulin resistance and inflammation.
Jialal I; Adams-Huet B; Duong F; Smith G
Metab Syndr Relat Disord; 2014 May; 12(4):227-30. PubMed ID: 24593134
[TBL] [Abstract][Full Text] [Related]
2. The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents.
Masquio DC; de Piano A; Campos RM; Sanches PL; Carnier J; Corgosinho FC; Netto BD; Carvalho-Ferreira JP; Oyama LM; Nascimento CM; de Mello MT; Tufik S; Dâmaso AR
Br J Nutr; 2015 Jun; 113(12):1920-30. PubMed ID: 25907896
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of leptin, adiponectin, retinol binding protein 4 and leptin/adiponectin molar ratio as another possible marker of insulin resistance in obese.
Tajtakova M; Petrasova D; Pidanicova A; Gallovicova A; Blanarova C; Petrovicova J
Bratisl Lek Listy; 2010; 111(4):212-5. PubMed ID: 20586148
[TBL] [Abstract][Full Text] [Related]
4. Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people.
Qi Q; Yu Z; Ye X; Zhao F; Huang P; Hu FB; Franco OH; Wang J; Li H; Liu Y; Lin X
J Clin Endocrinol Metab; 2007 Dec; 92(12):4827-34. PubMed ID: 17878249
[TBL] [Abstract][Full Text] [Related]
5. Serum retinol-binding protein 4 concentration and its ratio to serum retinol are associated with obesity and metabolic syndrome components in children.
Aeberli I; Biebinger R; Lehmann R; L'allemand D; Spinas GA; Zimmermann MB
J Clin Endocrinol Metab; 2007 Nov; 92(11):4359-65. PubMed ID: 17726085
[TBL] [Abstract][Full Text] [Related]
6. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".
Kanaka-Gantenbein C; Margeli A; Pervanidou P; Sakka S; Mastorakos G; Chrousos GP; Papassotiriou I
Clin Chem; 2008 Jul; 54(7):1176-82. PubMed ID: 18487287
[TBL] [Abstract][Full Text] [Related]
7. Increased adipose tissue insulin resistance in metabolic syndrome: relationship to circulating adipokines.
Adams-Huet B; Devaraj S; Siegel D; Jialal I
Metab Syndr Relat Disord; 2014 Dec; 12(10):503-7. PubMed ID: 25162912
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
9. Association of plasma retinol-binding protein-4, adiponectin, and high molecular weight adiponectin with metabolic adversities in patients with schizophrenia.
Chen PY; Huang MC; Chiu CC; Liu HC; Lu ML; Chen CH
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Dec; 35(8):1927-32. PubMed ID: 21840365
[TBL] [Abstract][Full Text] [Related]
10. Serum adiponectin, leptin, resistin and RBP4 levels in obese and metabolic syndrome children with nonalcoholic fatty liver disease.
Boyraz M; Cekmez F; Karaoglu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Oct; 7(5):737-45. PubMed ID: 24044566
[TBL] [Abstract][Full Text] [Related]
11. Insulin resistance, inflammatory biomarkers, and adipokines in patients with chronic kidney disease: effects of angiotensin II blockade.
de Vinuesa SG; Goicoechea M; Kanter J; Puerta M; Cachofeiro V; Lahera V; Gómez-Campderá F; Luño J
J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S206-12. PubMed ID: 17130263
[TBL] [Abstract][Full Text] [Related]
12. Association of urinary RBP4 with insulin resistance, inflammation, and microalbuminuria.
Park SE; Lee NS; Park JW; Rhee EJ; Lee WY; Oh KW; Park SW; Park CY; Youn BS
Eur J Endocrinol; 2014 Oct; 171(4):443-9. PubMed ID: 24994759
[TBL] [Abstract][Full Text] [Related]
13. The ratio of serum leptin to adiponectin provides adjunctive information to the risk of metabolic syndrome beyond the homeostasis model assessment insulin resistance: the Korean Genomic Rural Cohort Study.
Yoon JH; Park JK; Oh SS; Lee KH; Kim SK; Cho IJ; Kim JK; Kang HT; Ahn SG; Lee JW; Lee SH; Eom A; Kim JY; Ahn SV; Koh SB
Clin Chim Acta; 2011 Nov; 412(23-24):2199-205. PubMed ID: 21855536
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the relationship of leptin, high-sensitivity C-reactive protein, adiponectin, insulin, and uric acid to metabolic syndrome in lean, overweight, and obese young females.
Abdullah AR; Hasan HA; Raigangar VL
Metab Syndr Relat Disord; 2009 Feb; 7(1):17-22. PubMed ID: 19025443
[TBL] [Abstract][Full Text] [Related]
15. Relationship of adipokines (adiponectin, resistin and RBP4) with metabolic syndrome components in pubertal obese children.
Boyraz M; Cekmez F; Karaoğlu A; Cinaz P; Durak M; Bideci A
Biomark Med; 2013 Jun; 7(3):423-8. PubMed ID: 23734806
[TBL] [Abstract][Full Text] [Related]
16. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
17. Association of serum levels of retinol-binding protein 4 with male sex but not with insulin resistance in obese patients.
Ulgen F; Herder C; Kühn MC; Willenberg HS; Schott M; Scherbaum WA; Schinner S
Arch Physiol Biochem; 2010 May; 116(2):57-62. PubMed ID: 20222849
[TBL] [Abstract][Full Text] [Related]
18. Visfatin in obese children and adolescents and its association with insulin resistance and metabolic syndrome.
Nourbakhsh M; Nourbakhsh M; Gholinejad Z; Razzaghy-Azar M
Scand J Clin Lab Invest; 2015 Apr; 75(2):183-8. PubMed ID: 25723377
[TBL] [Abstract][Full Text] [Related]
19. Combined impact of adiponectin and retinol-binding protein 4 on metabolic syndrome in elderly people: the Korean Longitudinal Study on Health and Aging.
Lim S; Yoon JW; Choi SH; Park YJ; Lee JJ; Park JH; Lee SB; Kim KW; Lim JY; Kim YB; Park KS; Lee HK; Cho SI; Jang HC
Obesity (Silver Spring); 2010 Apr; 18(4):826-32. PubMed ID: 19661959
[TBL] [Abstract][Full Text] [Related]
20. The relationship between adipokines, metabolic parameters and insulin resistance in patients with metabolic syndrome and type 2 diabetes.
Lee JM; Kim SR; Yoo SJ; Hong OK; Son HS; Chang SA
J Int Med Res; 2009; 37(6):1803-12. PubMed ID: 20146878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
